An update on the plane crash in the French Alps. Saudi Arabia launches air strikes against Yemen rebel bases. And President Barack Obama slows U.S. troop withdrawal from Afghanistan. A panel of journalists joins Diane for analysis of the week's top international news stories.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
Most Recent Shows
The House passes a budget with no Democratic support. Republican Senator Ted Cruz enters the 2016 presidential race. And the Army charges Sergeant Bowe Bergdahl with desertion. A panel of journalists joins Diane for analysis of the week's top national news stories.
The United Nations has recently come under attack for its handling of both the Ebola outbreak and the war in Syria. It has prompted some to question what the role of the U.N. should be on the international stage. We look at the relevance of the U.N., 70 years after its creation.
Many doctors support Angelina Jolie's decision to have her ovaries removed two years after a preventive double mastectomy. We explore testing for BRCA genetic mutations and debate over surgery to reduce cancer risks.